StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Renalytix's profit margin for the twelve months ending Sep 30, 2024 was -1191.8%. For fiscal 2024 it was -1461.6%, against -1340.2% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Jun 30, 2024-1461.6%−121.4
FY2023Jun 30, 2023-1340.2%+184.2
FY2022Jun 30, 2022-1524.4%+845.5
FY2021Jun 30, 2021-2370.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2025CQ3 2024Sep 30, 2024-905.7%+1306.5
Q4 FY2024CQ2 2024Jun 30, 2024-1207.2%+936.5
Q3 FY2024CQ1 2024Mar 31, 2024-1447.3%+224.8
Q2 FY2024CQ4 2023Dec 31, 2023-1196.8%−320.6
Q1 FY2024CQ3 2023Sep 30, 2023-2212.2%−978.7
Q4 FY2023CQ2 2023Jun 30, 2023-2143.6%−1523.5
Q3 FY2023CQ1 2023Mar 31, 2023-1672.1%+137.6
Q2 FY2023CQ4 2022Dec 31, 2022-876.2%+937.1
Q1 FY2023CQ3 2022Sep 30, 2022-1233.5%+863.1
Q4 FY2022CQ2 2022Jun 30, 2022-620.1%+1460.4
Q3 FY2022CQ1 2022Mar 31, 2022-1809.7%−392.0
Q2 FY2022CQ4 2021Dec 31, 2021-1813.3%+468.2
Q1 FY2022CQ3 2021Sep 30, 2021-2096.7%–
Q4 FY2021CQ2 2021Jun 30, 2021-2080.5%–
Q3 FY2021CQ1 2021Mar 31, 2021-1417.8%–
Q2 FY2021CQ4 2020Dec 31, 2020-2281.5%–

More Renalytix figures

See a number that looks wrong?